Eric Crombez
EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE) since May 2023
Eric Crombez has filed 18 insider reports with the SEC since May 2023, as director at Abeona Therapeutics Inc. (ABEO) and EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE). In the last 12 months Eric Crombez sold $396K of stock on the open market. In the latest filing, on May 15, 2026, Eric Crombez sold 26,143 shares of Abeona Therapeutics Inc. (ABEO) for $145K at an average of $5.53.
- Filings
- 18
- Companies
- 2
- Bought on market
- None
- Sold on market
- $923K
Companies where Eric Crombez is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince August 2024 | 37,313 | $260K | $2.42 | May 15, 2026 | |||
| EVP and Chief Medical Officersince May 2023 | 111,189 | $663K | $16.48 | May 6, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 15, 2026-$145KABEODirector Crombez Eric sold $144,636 worth of shares (26,143 units at $5.53) as part of a pre-agreed trading plan, decreasing direct ownership by 41% to 37,313 unitsForm 4Open-market sale10b5-1 plan
- May 5, 2026-$8,586RAREEVP and Chief Medical Officer Crombez Eric sold $8,586 worth of shares (344 units at $24.96), decreasing direct ownership by 0.31% to 111,189 units to cover taxesForm 4Open-market sale
- Apr 16, 2026RARESEC Form 4 filed by Crombez EricForm 4Grant or award
- Mar 2, 2026-$160KRAREEVP and Chief Medical Officer Crombez Eric was granted 11,643 shares and sold $160,261 worth of shares (7,029 units at $22.80), increasing direct ownership by 7% to 76,301 unitsForm 4Grant or awardOpen-market sale
- Feb 2, 2026-$82.9KABEODirector Crombez Eric sold $82,895 worth of shares (16,284 units at $5.09), decreasing direct ownership by 20% to 63,456 unitsForm 4Open-market sale
- Jan 26, 2026ABEODirector Crombez Eric was granted 37,313 shares, increasing direct ownership by 88% to 79,740 unitsForm 4Grant or award
- Aug 14, 2025-$32.7KABEODirector Crombez Eric sold $32,683 worth of shares (4,718 units at $6.93), decreasing direct ownership by 10% to 42,427 unitsForm 4Open-market sale
- May 5, 2025-$28.9KRAREEVP and Chief Medical Officer Crombez Eric sold $28,901 worth of shares (762 units at $37.93), decreasing direct ownership by 0.55% to 71,530 unitsForm 4Open-market sale
- Mar 3, 2025-$377KRAREEVP and Chief Medical Officer Crombez Eric was granted 31,784 shares and sold $376,584 worth of shares (8,945 units at $42.10), increasing direct ownership by 49% to 71,922 unitsForm 4Grant or awardOpen-market sale
- Jan 31, 2025ABEODirector Crombez Eric was granted 36,101 shares, increasing direct ownership by 327% to 47,145 unitsForm 4Grant or award
- Aug 13, 2024ABEODirector Crombez Eric was granted 11,044 sharesForm 4Grant or award
- Aug 12, 2024ABEOEric Crombez became an insiderForm 3New insider
- May 2, 2024-$15.5KRARECrombez Eric sold $15,456 worth of shares (354 units at $43.66), decreasing direct ownership by 0.73% to 48,431 unitsForm 4Open-market sale
- Apr 18, 2024-$6,262RARECrombez Eric sold $6,262 worth of shares (142 units at $44.10), decreasing direct ownership by 0.29% to 48,785 unitsForm 4Open-market sale
- Mar 1, 2024-$66.6KRARECrombez Eric was granted 19,400 shares and sold $66,555 worth of shares (1,238 units at $53.76), increasing direct ownership by 60% to 48,927 unitsForm 4Grant or awardOpen-market sale
- Sep 27, 2023RARESEC Form 4 filed by Crombez EricForm 4Grant or award
- May 1, 2023RARESEC Form 4 filed by Crombez EricForm 4Grant or award
- May 1, 2023RARESEC Form 3: New insider Crombez Eric claimed ownership of 25,854 sharesForm 3New insider
Compare Eric Crombez with
- Eric Crombez vs Faith L. Charles1 shared
- Eric Crombez vs Vishwas Seshadri1 shared
- Eric Crombez vs Joseph Walter Vazzano1 shared
- Eric Crombez vs Brendan M. O'Malley1 shared
- Eric Crombez vs Madhav Vasanthavada1 shared
- Eric Crombez vs Theodore Alan Huizenga1 shared
Other insiders at the same companies
- Faith L. CharlesABEO
- Vishwas SeshadriABEO
- Joseph Walter VazzanoABEO
- Brendan M. O'MalleyABEO
- Madhav VasanthavadaABEO
- Theodore Alan HuizengaRARE
- Mark AlvinoABEO
- Karah Herdman ParschauerRARE
- Howard HornRARE
- Leila AllandABEO
- Christine Berni SilversteinABEO
- Sanders Corazon (Corsee) D.RARE
- Matthew K FustRARE
- Shehnaaz SulimanRARE
- Amrit RayRARE
- Michael NarachiRARE
Questions about Eric Crombez
- What is Eric Crombez's role at Ultragenyx Pharmaceutical Inc.?
- Eric Crombez reports to the SEC as EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), according to the latest filing on May 6, 2026. Eric Crombez has also filed as director at Abeona Therapeutics Inc. (ABEO).
- How many shares does Eric Crombez own?
- After the latest filing that states it, Eric Crombez directly owned 37,313 shares of Abeona Therapeutics Inc. (ABEO) and 111,189 shares of Ultragenyx Pharmaceutical Inc. (RARE). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eric Crombez bought or sold stock recently?
- The most recent open-market sale was on May 15, 2026: sold 26,143 shares of Abeona Therapeutics Inc. (ABEO) for $145K at an average of $5.53.
- How do I get alerts when Eric Crombez files?
- Follow Eric Crombez on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Eric Crombez (SEC CIK 0001653052). Totals count each trade once, skipping amendments whose original is on file, from May 2, 2023 on. View on SEC EDGAR · Get this as JSON